Correlation Between Johnson Johnson and C4 Therapeutics

Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Johnson Johnson and C4 Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and C4 Therapeutics.

Diversification Opportunities for Johnson Johnson and C4 Therapeutics

-0.49

Correlation Coefficient

Johnson Johnson  C4 Therapeutics

Very good diversification

The 3 months correlation between Johnson and CCCC is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Johnson Johnson and C4 Therapeutics

Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.26 times more return on investment than C4 Therapeutics. However, Johnson Johnson is 3.9 times less risky than C4 Therapeutics. It trades about 0.12 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.18 per unit of risk. If you would invest  15,378  in Johnson Johnson on November 29, 2024 and sell it today you would earn a total of  1,231  from holding Johnson Johnson or generate 8.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Johnson Johnson  vs.  C4 Therapeutics

Johnson Johnson

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in March 2025.

C4 Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Johnson Johnson and C4 Therapeutics

The main advantage of trading using opposite Johnson Johnson and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.

The idea behind Johnson Johnson and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.